Dentists in Hampstead, MD Accepting Medicare
8 Dentists found. Showing 1 - 8
 Dr. James Milton Resh, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1306 North Main St., Hampstead, MD 21074 Phone: 410-374-5900 |
Dr. Kevin Daniel Resh, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1306 N Main St, Hampstead, MD 21074 Phone: 410-374-5900 Fax: 410-239-2014 |
Dr. Eric Scott Resh, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1306 N Main St, Hampstead, MD 21074 Phone: 410-374-5900 Fax: 410-239-2014 |
Lawrence R Whitney Jr., D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2113 Hanover Pike, Hampstead, MD 21074 Phone: 410-374-5200 Fax: 410-374-0062 |
Dr. Eugene Duston Mersinger, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 695 Hanover Road, Hampstead, MD 21074 Phone: 410-239-8880 |
Dr. Theodore Vincent Szymanski, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2113 Hanover Pike, Hampstead, MD 21074 Phone: 410-374-5200 Fax: 410-374-0062 |
 Vilija Mickute, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2113 Hanover Pike, Hampstead, MD 21074 Phone: 410-374-5200 |
Dr. Rudolph E. Klima Jr., D.D.S P.A. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 4519 Lower Beckleysville Rd, Hampstead, MD 21074 Phone: 410-239-9724 Fax: 410-239-1468 |
News Archive
Hypericin may treat recurrent malignant brain tumors
Researchers have found that a synthetic version of hypericin, a compound naturally found in St. John's wort, may be a promising treatment for patients with recurrent malignant brain tumors. Their findings were published online on March 31, 2011 in the journal Cancer.
Research roundup: Community benefits and hospitals' tax-exempt status; Medicaid expansion could benefit people of color; Looking at changes for Medicare
The federal health law requires tax-exempt hospitals to assess and address the needs of the community in which they serve by the end of 2013.
EndoChoice granted FDA marketing clearance for BONASTENT Esophageal and Biliary Stent platforms
EndoChoice, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its BONASTENT® Fully Covered Esophageal Stent for the treatment of malignant esophageal obstructions, and its BONASTENT Uncovered Biliary Stent for the treatment of malignant biliary obstructions.
Poor information on diet, but exercise seems good for adult type 2 diabetes
There are no high quality data to assess how well dietary treatments for type 2 diabetes work in people who have just been told they have the disease, but there is evidence that taking on exercise seems to be one way of improving blood sugar levels, according to the findings of a Cochrane Systematic Review.
› Verified 6 days ago
Pharmacists
Counselors
Dentists
Clinical Social Workers
Occupational Therapists